INTRODUCTION
Myo-inositol, as a phospholipid constituent, was first reported in mycobacteria by R. J. Anderson in 1930 (1) . Subsequently, the presence of phosphatidyl-myo-inositol dimannosides (PIM 2 ) and phosphatidyl-myo-inositol pentamannosides (PIM 5 ) were recognized in Mycobacterium tuberculosis (2, 3) . Over the past 40 years, the structure of the complete family of phosphatidylmyo-inositol mannosides (PIM 1 -PIM 6 ) in various Mycobacterium spp. and related Actinomycetes has been defined, first as deacylated glycerol-myoinositol phosphoryl mannosides and later as the fully acylated native molecules (4) .
PIMs and metabolically-related lipoglycans comprising lipomannan (LM) and lipoarabinomannan (LAM) are non-covalently anchored through their phosphatidyl-myo-inositol (PI) moiety to the inner and outer membranes of the cell envelope (5, 6) and play various essential although poorly defined roles in mycobacterial physiology. They are also thought to be important virulence factors during the infection cycle of M. tuberculosis. Aided by the availability of a growing number of genome sequences from lipoglycan-producing Actinomycetes, developments in the genetic manipulation of these organisms and advances in our understanding of the molecular processes underlying sugar transfer in Corynebacterianeae, considerable progress was made over the last 10 years in identifying the enzymes associated with the biogenesis of PIM, LM and LAM (for recent review, [7] [8] . The precise chemical definition of these molecules from various Actinomycetes combined to comparative analyses of their interactions with the host immune 2 system also has shed light onto their structurefunction relationships (9) .
In this review, we will present some key enzymatic, structural and topological aspects of the biogenesis of PIMs, a pathway that may represent a paradigm for that of other mycobacterial complex (glyco)lipids. The elucidation of this pathway has helped in our understanding of the pathogenesis of TB and revealed new opportunities for drug discovery.
CHEMICAL STRUCTURE OF PHOSPHATIDYL-MYO-INOSITOL MANNOSIDES: AN OVERVIEW
The PIM family of glycolipids comprises PI mono-, di-, tri-, tetra-, penta-and hexamannosides with different degrees of acylation. PI-dimannosides (PIM 2 ) and PI-hexamannosides (PIM 6 ) are the two most abundant classes found in Mycobacterium bovis bacillus CalmetteGuérin (BCG), Mycobacterium tuberculosis H37Rv, and Mycobacterium smegmatis 607 (10) . The presence of myo-inositol and mannose as sugar constituents of phospholipids from M. tuberculosis was first reported by Anderson in the 1930s (1, (11) (12) (13) . Using similar approaches 25 years later, Lee and Ballou arrived at a complete structure of PIM 2 from M. tuberculosis and M. phlei and provided evidence of the existence of mono-, tri-, tetra-, and penta-mannoside variants (2, 3, 14, 15) . A reanalysis of PIMs from M. smegmatis under their deacylated form later revealed a structure based on that previously defined by Ballou et al. but containing 6 Manp residues (PIM 6 ) (16). The complete chemical structures of the acylated, native forms of PIM 2 and PIM 6 were later reinvestigated in M. bovis BCG and unequivocally established (Fig. 1A) (10, 17) . PIM 2 is composed of two Manp residues attached to positions 2-and 6-of the myo-inositol ring of PI. PIM 6 is composed of a pentamannosyl group, t-α-Manp(1→2)-α-Manp(1→2)-α-Manp(1→6)-α-Manp(1→6)-α-Manp(1→, attached to position 6 of the myo-inositol ring, in addition to the Manp residue present at position 2 (Fig. 1A) . Brennan and Ballou initially found that PIM 2 occurs in multiple acylated forms, where two fatty acids are attached to the glycerol moiety, and two additional fatty acids may esterify available hydroxyls on the Manp residue and/or the myo-inositol ring (Fig. 1A) (18) . The triand tetra-acylated forms of PIM 2 Suggestive of metabolic relationship, the reducing end of LM and LAM shares structural similarities with PIMs in that the myo-inositol residues of the PI of PIMs, LM and LAM are mannosylated at the 2-and 6-positions and similar fatty acyl chains esterify the glycerol moiety, the Manp linked to C2 of myo-inositol and the myoinositol ring (16, (19) (20) (21) .
PHOSPHATIDYL-MYO-INOSITOL DIMANNOSIDE BI OSYNTHESIS
Ac 1 PIM 2 and Ac 2 PIM 2 are considered both metabolic end products and intermediates in the biosynthesis of Ac 1 PIM 6 /Ac 2 PIM 6 , LM and LAM. According to the currently accepted model, PIM synthesis is initiated by the transfer of two Manp residues and a fatty acyl chain onto PI on the cytosolic face of the plasma membrane. The first step consists of the transfer of a Manp residue from GDP-Manp to the 2-position of the myo-inositol ring of PI to form PI-monomannoside (PIM 1 ) (15) (Fig. 1A 2 . Recent cell-free assays using pure enzymes alone or in combination with M. smegmatis membrane extracts indicated that although both pathways might co-exist in mycobacteria, the sequence of events PI→PIM 1 →PIM 2 →Ac 1 PIM 2 is favored (23). The acyltransferase responsible for the transfer of a fourth acyl group to position 3 of the myo-inositol ring has not yet been identified.
A major advance in our understanding of the molecular basis of the biosynthesis of the PIM 2 family was provided by the structural characterization of PimA from M. smegmatis mc 2 155 (26). PimA is not only a key player in the biosynthetic pathway of PIM, it is also a paradigm of a large family of peripheral membrane-associated glycosyltransferases (GTs) the molecular mechanisms of substrate/membrane recognition and catalysis of which are poorly understood. The PimA enzyme, which belongs to the ubiquitous GT4 family of retaining GTs (CAZy; carbohydrateactive enzyme database), displays the typical GT-B fold of GTs ( Fig. 2A ) (26) (27) . The crystal structure of a PimA-GDP-Manp complex revealed that the enzyme adopts a 'closed' conformation in the presence of GDP-Manp, with the GDP moiety of the sugar donor substrate making binding interactions predominantly with the C-terminal domain of the protein (Fig. 2B) . The 3D structure also provided clear insights into the architecture of the lipid-acceptor binding site. Docking calculations and site-directed mutagenesis validated the position of the polar head of the lipid acceptor, myo-inositol phosphate, in a welldefined pocket with its O2 atom favorably positioned to receive the Manp residue from GDP-Manp (Fig. 2B) (28) .
More recently, experimental evidence based on structural, calorimetric, mutagenesis and enzyme activity studies indicated that PimA undergoes significant conformational changes upon substrate binding that seem to be important for catalysis. Specifically, the binding of the donor substrate GDP-Manp triggered an important interdomain rearrangement from an 'open' to a 'closed' state that stabilized the enzyme and considerably enhanced its affinity for the acceptor substrate, PI. The interaction of PimA with the β-phosphate of GDP-Manp was essential for this conformational change to occur. The 'open' to 'closed' motion brings together critical residues from the N-and Cterminal domains, allowing the formation of a functionally competent active site. In contrast, the binding of PI to the enzyme, had the opposite effect, inducing the formation of a more relaxed complex with PimA. It could be speculated that PI binding allows the initiation of the enzymatic reaction and induces the 'opening' of the protein allowing the product to be released. Interestingly, GDP-Manp stabilized and PI destabilized, PimA by a similar enthalpic amount, suggesting that they form or disrupt an equivalent number of interactions within PimA complexes. Altogether, our experimental data support a model wherein flexibility and conformational transitions confer upon PimA the adaptability to the donor and acceptor substrates required for catalysis (28) . In this regard, PimA thus seems to follow an ordered mechanism similar that reported for other GT-B enzymes (29) (30) .
Another key aspect of the mode of action of PimA is its interaction with membranes. To perform their biochemical functions, membraneassociated GTs interact with membranes by two different mechanisms. Whereas integral membrane GTs are permanently attached through transmembrane regions (e.g. hydrophobic α-helices) (31), peripheral membrane-associated GTs temporarily bind membranes by (i) a stretch of hydrophobic residues exposed to bulk solvent, (ii) electropositive surface patches that interact with acidic phospholipids (e.g. amphipathic α-helices), and/or (iii) protein-protein interactions (32) (33) (34) (35) . A close interaction of the ManTs PimA and PimB' with membranes is likely to be a strict requirement for PI/PIM modification. Consistent with this hypothesis, the membraneassociation of PimA via electrostatic interactions is suggested by the presence of an amphipathic α-helix and surface-exposed hydrophobic residues in the N-terminal domain of the protein (Fig. 2B) . Despite the fact that sugar transfer is catalyzed between the mannosyl group of the GDP-Manp donor and the myoinositol ring of PI, the enzyme displayed an absolute requirement for both fatty acid chains of the acceptor substrate in order for the transfer reaction to take place. Most importantly, while PimA was able to bind monodisperse PI, its transferase activity was stimulated by high concentrations of nonsubstrate anionic surfactants, indicating that the reaction requires a lipid-water interface (26) . Interestingly, critical residues and their interactions are preserved in PimA and PimB' strongly supporting conserved catalytic and membrane association mechanisms (23).
BIOSYNTHESIS OF PHOSPHATIDYL-MYO-INOSITOL PENTA-AND HEXA-MANNOSIDES, LM AND LAM
Ac 1 PIM 2 and Ac 2 PIM 2 can be further elongated with additional Manp residues to form higher PIM species, such as Ac 1 PIM 3 -Ac 1 PIM 6 /Ac 2 PIM 3 -Ac 2 PIM 6 , or LM and LAM (Fig. 1B) . It has been proposed that the third Manp residue of PIM is added to Ac 1 PIM 2 by the non-essential GDP-Manp-utilizing the ManT, PimC, identified in the genome of M. tuberculosis CDC1551 (36 (31, (37) (38) . PimE (Rv1159) has been recently identified as an α-1,2-Man T involved in the biosynthesis of higher order PIMs. PimE belongs to the GT-C superfamily of GTs which comprises integral membrane proteins that use polyprenyl-linked sugars as donors (7) (8) 27, 31) . A combination of phenotypic characterization of M. tuberculosis and M. smegmatis pimE knock-out mutants and cell-free assays clearly indicated that PimE transfers a Manp residue from polyprenolphosphate-mannose (PPM) to Ac 1 PIM 4 , to form Ac 1 PIM 5 at the periplasmic face of the plasma membrane (Fig. 1A, B ) (31; our unpublished results). The α-1,2-Man T responsible for the formation of PIM 6 from PIM 5 is not yet known.
A screening for M. smegmatis transposon mutants with defects in cell envelope synthesis led to the discovery of a mutant harboring an insertion in the putative lipoprotein-encoding gene, lpqW (orthologous to Rv1166 of M. tuberculosis H37Rv). On complex media, the mutant formed small colonies that produced much reduced quantities of LAM compared to the wild-type parent strain. This phenotype was unstable, however, as the mutant rapidly evolved to give rise to variants that had restored LAM biosynthesis but failed to produce higher PIMs and accumulated the branch point intermediate Ac 1 PIM 4 (39) . Consistent with the accumulation of this intermediate, the restoration of LAM synthesis in the lpqW mutant was accounted for by secondary mutations in the pimE gene affecting the extracytoplasmic enzymatic activity of this protein (40) . From these findings, it was proposed that LpqW is required to channel PIM 4 into LAM synthesis (Fig. 1B) and that loss of PimE which results in the accumulation of high levels of Ac 1 PIM 4 in the cells bypasses the need for LpqW (40) . The crystal structure of LpqW (41) revealed an overall fold (Fig. 2C ) that resembles those of a family of bacterial substrate-binding proteins (42) . The authors suggest a plausible model in which an electronegative interdomain cavity in LpqW might bind the Ac 1 PIM 4 intermediate (Fig. 2C) to channel it into the LM/LAM biosynthetic pathway, thus controlling the relative abundance of higher PIMs and LM/LAM (Fig. 1B) .
COMPARTMENTALIZATION OF THE PIM BIOSYNTHETIC PATHWAY AND TRANSLOCATION OF PIMS ACROSS THE CELL ENVELOPE
As evidenced by the nature of the GTs and sugar donors involved, and the asymmetrical PIM composition of the inner and outer leaflets of the mycobacterial plasma membrane (43), the biosynthesis of PIM, LM and LAM is topologically complex. Whereas the first two mannosylation steps of the pathway at least involve GDP-Manp-dependent enzymes and occur on the cytoplasmic face of the plasma membrane (22) (23) 38, 43) , further steps in the biosynthesis of the higher more polar forms of PIMs (PIM 5 -PIM 6 , under their various acylated forms), and metabolically-related LM and LAM appear to rely upon integral membrane GT-C-type GTs and to take place on the periplasmic side of the membrane (7,31,43-44, our unpublished results) (Fig. 1B) . Thus, similar to other M. tuberculosis glycolipids such as sulfolipid-I and the linker unit of the mycobacterial cell wall (for a recent review, 8), PIMs clearly display a compartmentalized biosynthetic pathway organized around the inner and outer leaflets of the plasma membrane. Such a compartmentalization implies the translocation of PIM intermediates (i.e., either PIM 2 , PIM 3 and/or PIM 4 ) from the cytoplasmic to the periplasmic side of the membrane. Likewise, much like the lipidlinked oligosaccharides involved in the biosynthesis of bacterial (lipo)polysaccharides and peptidoglycan (45) (46) (47) , it is expected that PPM is translocated to the periplasmic side of the plasma membrane to serve as the Manp donor in the glycosyl transfer reactions catalyzed by PimE and subsequent GT-C ManTs of the PIM, LM and LAM pathway. Beyond the plasma membrane, since two different populations of PIMs -one associated to the inner membrane and the other associated with the outer membrane -have been described (2, 48) , there must exist transporters responsible for their translocation across the periplasm and to the cell surface. None of the transporters involved in these processes have yet been identified.
KNOWNS AND UNKNOWNS ABOUT THE PHYSIOLOGICAL ROLES AND BIOLOGICAL ACTIVITIES OF PIMs
The role of PIMs in the physiology of mycobacteria remains unclear. Since in M. bovis BCG PI and PIMs make up as much as 56% of all phospholipids in the cell wall and 37% of those in the plasma membrane, these molecules have long been thought to be essential structural components of the mycobacterial cell envelope (48) . Drugsusceptibility testing and uptake experiments with norfloxacin or chenodeoxycholate performed on recombinant M. smegmatis and M. tuberculosis strains affected in their polar or apolar PIM contents clearly implicated these glycolipids in the permeability of the cell envelope to both hydrophilic and hydrophobic molecules (22, 31, 49) . Recent electron microscopy studies on a pimE-deficient mutant of M. smegmatis further pointed to a role of higher-order PIMs in cell membrane integrity and in the regulation of cell septation and division (31) . Somewhat supporting these observations, polar and apolar PIM production was reported to be affected by environmental factors known to impact replication rate and/or membrane fluidity, such as carbon/nitrogen sources and temperature (50) (51) . The amount of higher-order PIMs (PIM 5 -PIM 6 ) recovered from mycobacterial cells increases with the age of the culture, probably at the expense of the apolar forms (PIM 1 -PIM 4 ) whose synthesis was shown to decrease in M. smegmatis when cultures enter stationary phase (43, (52) (53) . The regulatory mechanisms involved, and the specific steps of the PIM pathway at which they act, whether exclusively at the level of LpqW or otherwise, are not known. While higher-order PIMs are dispensable molecules in M. smegmatis, M. bovis BCG and M. tuberculosis (31,54, our unpublished results), such is not the case of PIM 1 and PIM 2 whose disruption causes immediate growth arrest in both fast-and slow-growing mycobacteria (22) (23) . Interestingly, we found the disruption of the acyltransferase Rv2611c to be lethal to M. tuberculosis H37Rv and to result in severe growth defects in M. smegmatis (25, our unpublished results), emphasizing the critical physiological impact of not only the degree of mannosylation of PIMs but also their acylation state.
Much of what is known of the roles of PIMs in host-pathogen interactions is derived from in vitro studies using various cell models and purified PIM molecules or whole mycobacterial cells (for recent reviews, 9,55-57). PIMs are major non-peptidic antigens of the host innate and acquired immune responses. They are TLR-2 agonists and stimulate unconventional αβ T lymphocytes in the context of CD1 proteins. Importantly, PIMs are also recognized by the Ctype lectins, mannose receptor (MR), mannosebinding protein (MBP), and DC-SIGN and, as such, play a role in the opsonic and non-opsonic binding of M. tuberculosis to phagocytic and nonphagocytic cells. The higher forms of PIMs, in particular, which contain two α(1→2)-linked Manp residues, identical to the dimannoside motif decorating the non-reducing termini of the arabinosyl side chains of ManLAM, have been shown to share with ManLAM the ability to engage the mannose and DC-SIGN receptors of phagocytic cells and, in so doing, to impact phagosome-lysosome fusion in cultured human monocyte-derived macrophages (54, 58) . Both the fatty acyl appendages of PIMs and their degree of mannosylation are important to their interactions with host cells. A better understanding of their roles in the pathogenesis of TB, however, would greatly benefit from the availability of M. tuberculosis mutants deficient either in their synthesis (wherever possible) or transport to the cell surface.
CONCLUDING REMARKS AND FUTURE CHALLENGES
Considerable advances have been made over the last 10 years in understanding the genetics and biochemistry of PIM synthesis in M. tuberculosis. Foremost among these advances has been the structural characterization of PimA -in fact the very first crystal structure of a GT involved in mycobacterial cell wall biosynthesis -and the proposal of a model for interpreting the conformational changes and membrane interactions associated with its catalytic mechanism. This model may represent a paradigm for other cytosolic bacterial cell wall biosynthetic enzymes working at the interface with the plasma membrane. Our current knowledge of the molecular mechanisms of substrate/membrane recognition by PimA and PimB' in turn place us in an unprecedented position to identify inhibitors of these enzymes and develop new drugs with bactericidal mechanisms different from those of presently available agents. Yet, considerable challenges remain to be overcome to fully understand the biosynthetic machinery of PIMs, their translocation to the cell surface, their roles in the physiology of mycobacteria and their contribution to host-pathogen interactions. Amongst the biochemistry challenges are, i) the identification of the third and fourth α-1,6-ManTs of the pathway, PimC and PimD, that of the α-1,2-ManT catalyzing the formation of PIM 6 from PIM 5 , and that of the acyltransferase responsible for the acylation of position 3 of myo-inositol; ii) the elucidation of the transport machinery responsible for the translocation of PIM intermediates and lipid-linked sugars across the inner membrane, and for the transport of the presumably fully assembled higher-and lowerforms of PIMs to the cell-surface; iii) the elucidation of the crystal structure of PIM biosynthetic enzymes in complex with PI or PIMs and, iv) the discovery of potent inhibitors of the PIM pathway which would not only provide bases for the rational design of novel drugs targeting M. tuberculosis but also be useful to probe the physiological functions of PIM, LM and LAM during in vitro growth and in the course of host infection. One Manp residue (in beige) is attached to position 2 of myo-inositol (in red), whereas the total number of Manp residues attached to position 6 may range from zero to five. In PIM 2 , the myo-inositol ring is glycosylated with a Manp unit at each of positions 2 and 6 (beige). In PIM 4 , a dimannosyl unit, t-α-Manp(1→6)-α-Manp(1→6) (yellow), further extends the Manp linked to position 6 of the myoinositol ring of PIM 2 . PIM 6 results from the elongation of PIM 4 by the dimannosyl unit t-α-Manp(1→2)-
FOOTNOTES

α-Manp(1→2) (orange). B. Topology model for the biosynthesis of PIMs, LM and LAM in mycobacteria.
See text for details. The precise identity(ies) of the PIM intermediate(s) translocated from the cytosolic to the periplasmic side of the plasma membrane, whether (Ac 1/2 )PIM 2 , (Ac 1/2 )PIM 3 or (Ac 1/2 )PIM 4 , remain(s) to be determined. The biosynthesis of PIMs takes place on both sides of the inner membrane. Synthesis is initiated on the cytoplasmic side where Manp is transferred from GDP-Manp to PI, followed by one to three additional Manp residues. On the periplasmic side, the mannolipid is extended by additional Manp residues up to PIM 6 . The enzymes involved belong to the GT-C fold family of glycosyltransferases, which are predicted to have between 8 to 13 trans-membrane α-helices with the active site located on an extra-cytoplasmic loop. Subsequent mannosylation and arabinosylation steps in LM and LAM biosynthesis (light blue, Manp residues; dark blue, Araf residues; white, Manp-capping residues) are thought to all take place on the periplasmic side of the plasma membrane requiring polyprenyl-phosphatesugar donors. As an important part of the literature on the biosynthesis of PIM, LM and LAM refers to the M. tuberculosis H37Rv genes, the Rv numbers of the proteins required for the different catalytic steps of the pathway are indicated. The M. tuberculosis CDC1551 nomenclature was used in the case of pimC (MT1800) as this gene lacks an ortholog in H37Rv. and myo-inositol phosphate (IP) binding sites, and the amphipathic α2 helix involved in membrane association is shown. Membrane attachment is mediated by an interfacial binding surface on the Nterminal domain of the protein, which likely includes a cluster of basic residues and the adjacent exposed loop β3-α2. Protein-membrane interactions stimulate catalysis by facilitating substrate diffusion from the lipid bilayer to the catalytic site and/or by inducing allosteric changes in the protein. C. Overall structure and proposed mode of action for LpqW. LpqW is predicted to be a monomeric membrane-associated lipoprotein comprising 600 amino acids (62.9 kDa). The crystal structure revealed that the protein is organized in two lobes. Three structural domains (I, II and III) can be identified, with domains I (magenta) and II (orange) representing the "lower" lobe (lobe 1), and domain III (yellow) the "upper" lobe (lobe 2). Although the structure of LpqW was determined in the non-liganded state, the authors were able to accommodate the major periplasmic component of PIM 4 (t-α-Manp(1→6)-α-Manp(1→6)) by using in silico docking. It is proposed that LpqW functions at the divergence point of the polar PIM and LM/LAM biosynthetic pathways to control the relative abundance of these species in the mycobacterial cell envelope. 
